Drug
Arct 032
Arct 032: highest development phase Phase 2, developed by Arcturus Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Arcturus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARCT-032 NCT06747858 | Phase 2 | Cystic Fibrosis |
| ARCT-032 NCT05712538 | Phase 1 | Cystic Fibrosis |
Latest
No recent events.
Follow Arct 032 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.